Berger Rachel Pardes, Beers Sue R, Richichi Rudolph, Wiesman Daniel, Adelson P David
Department of Pediatrics, Division of Child Advocacy, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Safar Center for Resuscitation Research, Pittsburgh, Pennsylvania 15213, USA.
J Neurotrauma. 2007 Dec;24(12):1793-801. doi: 10.1089/neu.2007.0316.
Predicting outcome after pediatric traumatic brain injury (TBI) is important for providing information to families and prescribing rehabilitation services. The study objective was to assess whether biomarkers concentrations obtained at the time of injury are associated with outcome. Serial serum concentrations of neuron-specific enolase (NSE), S100B and myelin basic protein (MBP) were measured in 152 children with acute TBI. Outcome was assessed with the Glasgow Outcome Scale (GOS) score and/or GOS-Extended Pediatric (GOS-E Peds). Spearman's rank correlation and binary logistic regression assessed the relationship between biomarker concentrations and outcome. For all biomarkers and time points, higher biomarker concentrations were associated with worse outcome. Initial and peak NSE concentrations and initial MBP concentrations were more strongly correlated with outcome in children < or =4 years compared with those >4 years of age. Using binary logistic regression to evaluate the simultaneous affect of all biomarkers on outcome, there was significant overall model fit predicting a dichotomous GOS from biomarker concentrations with a 77% correct classification rate and a negative and positive predictive value of 97% and 75%, respectively. We conclude that NSE, S100B, and MBP concentrations obtained at the time of TBI may be useful in predicting outcome. Future studies should focus on assessing the differential benefit of biomarkers compared with clinical variables and in assessing a continuous rather than categorical outcome variable.
预测小儿创伤性脑损伤(TBI)后的预后对于向家庭提供信息和制定康复服务处方非常重要。本研究的目的是评估损伤时获得的生物标志物浓度是否与预后相关。对152例急性TBI患儿测定了神经元特异性烯醇化酶(NSE)、S100B和髓鞘碱性蛋白(MBP)的系列血清浓度。采用格拉斯哥预后量表(GOS)评分和/或格拉斯哥扩展儿童预后量表(GOS-E Peds)评估预后。Spearman秩相关和二元逻辑回归分析评估生物标志物浓度与预后之间的关系。对于所有生物标志物和时间点,生物标志物浓度越高,预后越差。与4岁以上儿童相比,4岁及以下儿童的初始和峰值NSE浓度以及初始MBP浓度与预后的相关性更强。使用二元逻辑回归评估所有生物标志物对预后的同时影响,通过生物标志物浓度预测二分法GOS的整体模型拟合显著,正确分类率为77%,阴性和阳性预测值分别为97%和75%。我们得出结论,TBI时获得的NSE、S100B和MBP浓度可能有助于预测预后。未来的研究应集中在评估生物标志物与临床变量相比的差异益处,以及评估连续而非分类的预后变量。